Phase

phase 1 (159)

n/a (150)

phase 2 (150)

phase 3 (97)

phase 1/phase 2 (63)

phase 4 (17)

phase 2/phase 3 (16)

early phase 1 (13)

Study Documents

Study Protocol (5)

Individual Participant Data Set (4)

Clinical Study Report (2)

Dataset Specification (2)

Informed Consent Form (2)

Statistical Analysis Plan (2)

Annotated Case Report Form (1)

Study summary and schematic, -design, adverse event(s), -interventions,-medications, -demographics, and -files. (1)

Study summary, -design, -summary of participant assessments, -interventions, -medications, -demographics, -lab tests, -study files et al. (1)

Funder Type

Industry (446)

Other (382)

NIH (48)

U.S. Fed (3)

Study Type

Interventional (665)

Observational (198)

Observational [Patient Registry] (10)

Expanded Access (6)

KISIMA-01

Showing 876 - 879 of 879

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) Trial in United States (Testosterone Gel

Completed

Primary or Secondary Hypogonadism
Constitutional Delay in Growth and Puberty (CDGP)

Testosterone Gel (1%)

Birmingham, Alabama
+8 more

Dec 23, 2006

Multiple Sclerosis Trial in Ramat Gan (T cell vaccination)

Unknown status

Multiple Sclerosis

T cell vaccination

Ramat Gan, Israel

Sheba Medical Center

Aug 27, 2006

Coronary Disease, Heart Valve Diseases Trial in United States (CTI-01 (ethyl pyruvate))

Terminated

Coronary Disease
Heart Valve Diseases

CTI-01 (ethyl pyruvate)

Laguna Hills, California
+16 more

Mar 15, 2006

HIV Trial in Research Triangle Park (Zidovudine)

Completed

HIV Infections

Zidovudine

Research Triangle Park, North Carolina

Glaxo Wellcome Inc

Jun 23, 2005